Role of natural antioxidants in the therapeutic management of hepatocellular carcinoma

Abstract

Hepatocellular carcinoma (HCC) is a growing health problem in humans. HCC is considered the most common of internal malignancy which cause the death of human, but in the developed Western world, HCC is less common accompanied by increasing essentially in incidence, due to it occurs specially in chronic liver disease. HCC associated with various risk factors including hepatitis B virus infection; hepatitis C virus infection; prolonged aflatoxin exposure; and alcoholic cirrhosis. Overall, one-third of cirrhosis patients will develop HCC during their life time. Also, chemical carcinogens cause tumor promotions through free radical metabolites result in many biochemical and molecular changes that induces oxidative stress. The identify of HCC stage and underlying liver status then choosing the most appropriate line of therapy (surgical, loco regional, radiological and medical) can be improve the survival and/or the quality of life of the patient. Taken into the account of the nutritional value of some natural antioxidant agents that support the function of the body resulting an improvement of the health and protection from different diseases, our review will provide an up-dated status of the different aspects of HCC management through covering the efficacy and the beneficial effects of different natural agents and their mechanism of action against HCC for the future therapy modalities.

Keywords

Hepatocellular carcinoma / risk factors / natural antioxidants

References

[1] Jemal A,Center MM,Ward E.Global cancer statistics..CA Cancer J Clin2011;61:69-90

[2] Marquardt JU,Teufel A.Hepatocellular carcinoma molecular pathogenesis and novel targets for therapy..Dutch Med Wochenschr2012;137:855-60

[3] Poon D,Chen LT,Lau WY,Singh H,Ooi LL,Khin MW,Asian Oncology Summit.Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009..Lancet Oncol2009;10:111-8

[4] Gomaa AI,Toledano MB,Taylor-Robinson SD.Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis..World J Gastroenterol2008;14:4300-8 PMCID:PMC2731180

[5] Velázquez RF,Navascués CA,Pérez R,Martínez I.Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis..Hepatol J2003;37:520-7

[6] Choi BG,Byun JY,Choi KH.The findings of ruptured hepatocellular carcinoma on helical CT..Br J Radiol2001;74:142-6

[7] Kew MC.Tumors of the liver..In: Zakim D, Boyer T, editors. Hepatology: A textbook of liver disease. 3rd ed.1996;PhiladelphiaWB Saunders Company1513

[8] Rossetto D,Kron SJ.Epigenetic modifications in double-strand break DNA damage signaling and repair..Clin Cancer Res2010;16:4543-52 PMCID:PMC2940951

[9] Kassianides C.The clinical manifestations and natural history of hepatocellular carcinoma..Gastroenterol Clin North Am1987;16:553-62

[10] McGlynn KA.The global epidemiology of hepatocellular carcinoma: present and future..Clin Liver Dis2011;15:223-43 PMCID:PMC4141529

[11] El-Serag HB.Hepatocellular carcinoma..N Engl J Med2011;365:1118-27

[12] Bruix J,Practice Guidelines Committee.Management of hepatocellular carcinoma..Hepatology2005;42:1208-36

[13] Besaratinia A,Hainaut P.In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure..Gastroenterology2009;137:1127-37 PMCID:PMC2736365

[14] Donato F,Gelatti U,Boffetta P,Decarli A,Ribero ML,Porru S.Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women..Am J Epidemiol2002;155:323-31

[15] Trichopoulos D,Lagiou P,Trepo E,Pischon T,Overved K,Outzen M,Kaaks R,Boeing H,Benetou V,Palli D,Panico S,Sacerdote C,Van Kranen HJ,Lund E,González CA,Navarro C,Barricarte A,Regnér S,Hallmans G,Wareham N,Romieu I,Murphy N,Trichopoulou A.Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study..J Natl Cancer Inst2011;103:1686-95 PMCID:PMC3216968

[16] Regimbeau JM,Vauthey JN,Durand F,Ikai I,Belghiti J.Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study..J Surg Oncol2004;85:36-41

[17] Sanyal AJ,Lencioni R.The etiology of hepatocellular carcinoma and consequences for treatment..Oncologist2010;4:14-22

[18] Dragani TA.Risk of HCC: genetic heterogeneity and complex genetics..J Hepatol2010;52:252-7

[19] Sohal DP.Hepatocellular carcinoma: prevention and therapy..Curr Oncol Rep2011;13:186-94

[20] Aravalli RN,Cressman EN.Molecular mechanisms of hepatocellular carcinoma..Hepatology2008;48:2047-63

[21] Farazi PA,Horner J.Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression..Cancer Res2006;66:4766-73

[22] Bialecki ES.Diagnosis of hepatocellular carcinoma..HPB (Oxford)2005;7:26-34 PMCID:PMC2023919

[23] Jiang J,Xu N.Influence of liver cancer on lipid and lipoprotein metabolism..Lipids Health Dis2006;5:4 PMCID:PMC1420303

[24] Das UN,Sravan Kumar G,Sangeetha P.Can tumor cell drug resistance be reversed by essential fatty acids and their metabolites?.Prostaglandins Leukot Essent Fatty Acids1998;58:39-54

[25] Tapiero H,Couvreur P.Polyunsaturated fatty acids (PUFA) and eicosanoids in human health and pathologies..Biomed Pharmacother2002;56:215-22

[26] Honarmand H,Rahbar-Taromsari M,Mirblock F.The relationship and diagnostic value of C-reactive protein (CRP) and C-reactive protein (hsCRP) for myocardial infarction..Afr J Microbiol Res2011;5:3215-9

[27] Hutchinson DR,Smith MG.Serum "prealbumin" as an index of liver function in human hepatobiliary disease..Clin Chem Acta1981;114:69-74

[28] Ahmed KM,Sayed EM.Anti-inflammatory effect ofdifferent propolis extracts in thioacetamide-induced hepatotoxicity in male rat..Aust J Basic App Sci2012;6:29

[29] Marra M,Lombardi A,Tarantino L,Stiuso P,Sperlongano R,Agresti M,Sperlongano P.Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview..J Transl Med2011;9:171 PMCID:PMC3213217

[30] Hassan HA,El-Gamel EM.Amelioration of cisplatin-induced nephrotoxicity by grape seed proanthocynidin extract and fish oil is mediated by lowering oxidative stress and DNA damage..Cytotechnology2014;66:419-29 PMCID:PMC3973798

[31] Banakar MC,Chattopadhyay MB,Chakraborty P.1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital..World J Gastroenterol2004;10:1268-75 PMCID:PMC4622764

[32] Revathi R.The effects of Umbelliferone on lipid peroxidation and antioxidant status in diethylnitrosamine induced hepatocellular carcinoma..Acute J Med2013;3:73-82

[33] Chen B,Yang G.Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats..Molecules2012;17:4672-83

[34] Trush MA.Role of free radicals in carcinogenic activation..In: Sies H, editor. Oxidative Stress: Oxidants and Antioxidants.1991;London, UKAcademic Press277-318

[35] Ljubuncic P,Cogan U,Bomzon A.The effects of aqueous extracts prepared from the leaves of Pastacia lentiscus in experimental liver disease..J Ethnopharmacol2005;100:198-204

[36] Ahmad A,Najmi AK,Pal SN.Evaluation of hepatoprotective potential of jigrine post-treatment against thioacetamide induced hepatic damage..J Ethnopharmacol2002;79:35-41

[37] Chilakapati J,Hill RA,Latendresse JR.Toxicokinetics and toxicity of thioacetamide sulfoxide: a metabolite of thioacetamide..Toxicology2007;230:105-16

[38] Cervello M.Cyclooxygenases in hepatocellular carcinoma..World J Gastroenterol2006;12:5113-21 PMCID:PMC4088007

[39] Coward WR,Sagara H,Holgate ST.NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?.J Immunol2002;169:5287-93

[40] Zaret KS.Generation and regeneration of cells of the liver and pancreas..Science2008;322:1490-4 PMCID:PMC2641009

[41] Lee S,Kim JH,Jang JJ.Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis..Am J Pathol2003;163:1371-8

[42] Nishikawa H,Tawara I,Kuribayashi K,Schreiber RD,Shiku H.IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response..J Immunol2005;175:4433-40

[43] Huether A,Sutter AP,Schuppan D.Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer..World J Gastroenterol2006;12:5160-7

[44] Hu S,Li XK,Mei ZN.Antitumor effects of chi-shen extract from Salvia miltiorrhiza and Paeoniae radix on human hepatocellular carcinoma cells..Acta Pharmacol Sin2007;28:1215-23

[45] Youle RJ.The BCL-2 protein family: opposing activities that mediate cell death..Nat Rev Mol Cell Biol2008;9:47-59

[46] Paradis V.Histopathology of hepatocellular carcinoma..In: Vauthey JN, Brouquet A, editors. Multidisciplinary treatment of hepatocellular carcinoma.2013;BerlinSpringer21-32

[47] Omata M,Tatter D.Sclerosing hepatic carcinoma: relationship to hypercalcemia..Liver1981;1:33-49

[48] Kojiro M,Kakizoe S,Kiyomatsu K.Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy..Can Chemother Pharmacol1989;23:S4-8

[49] Guy J,Roberts J,Yao F.Multidisciplinary management of hepatocellular carcinoma..Clin Gastroenterol Hepatol2012;10:354-62

[50] Kaseb AO,Roses RE.Multidisciplinary management of hepatocellular carcinoma..Recent Results Cancer Res2013;190:247-59

[51] Gish RG,Di Bisceglie AM,Mazzaferro V.Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma..Expert Rev Gastroenterol Hepatol2012;6:173-85

[52] Osaki A,Kamimura K,Tamura Y,Igarashi M,Yamagiwa S.A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma..Cancer Med2013;2:86-98 PMCID:PMC3797567

[53] Mok TS,Lee SD,Chan AT,Lui MC,Chak K,Johnson P.A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma..Cancer Chemother Pharmacol1999;44:307-11

[54] Leichman CG,Modiano M,Zalupski MM,Fletcher WS.Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: a Southwest Oncology Group pilot trial..Cancer1999;86:775-81

[55] Hassan HA.Obesity and clinical riskiness relationship: therapeutic management by dietary antioxidant supplementation-a review..Appl Biochem Biotechnol2015;176:647-69

[56] Kuppusamy P,Maniam GP,Soundharrajan I.Nutraceuticals as potential therapeutic agents for colon cancer: a review..Acta Pharm Sinica B2014;4:173-81 PMCID:PMC4629076

[57] Sousa GT,Rosa JC,Oyama LM,Pimentel GD.Dietary whey protein lessens several risk factors for metabolic diseases: a review..Lipids Health Dis2012;11:67 PMCID:PMC3393628

[58] Kapadia GJ,Takayasu J,Takasaki M,Tokuda H.Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs..Cancer Lett2000;161:221-9

[59] Kelloff GJ.Perspectives on cancer chemoprevention research and drug development..Adv Cancer Res2000;78:199-334

[60] Bravo L.Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance..Nutr Rev1998;56:317-33

[61] Yamashita H,Matsui-Yuasa I.Ecklonia cava polyphenol has a protective effect against ethanol-induced liver injury in a cyclic AMP-dependent manner..Mar Drugs2015;13:3877-91 PMCID:PMC4483661

[62] Manach C,Morand C,Jiménez L.Polyphenols: food sources and bioavailability..Am J Clin Nutr2004;79:727-47

[63] Xiao ZP,Peng MJ,Ouyang YZ.Flavonoids health benefits and their molecular mechanism..Mini Rev Med Chem2011;11:169-77

[64] Donfack JH,Ngameni B,Kerr PG,Vidari G,Buonocore D,Moundipa PF.Antihepatotoxic and antioxidant activities of methanol extract and isolated compounds from Ficus chlamydocarpa.Nat Prod Commun2010;5:1607-12

[65] Jamshidzadeha A,Dehghanib Z.Hepatoprotective activity of Cichorium intybus L. leaves extract against carbon tetrachloride induced toxicity..Iran J Pharm Res2006;1:41-6

[66] Mulabagal V,Ngouajio M.Characterization and quantification of health beneficial anthocyanins in leaf chicory (Cichorium intybus) varieties..Eur Food Res Technol2009;230:47-53

[67] Nayeemunnisa A.Alloxan diabetes-induced oxidative stress and impairment of oxidative defense system in rat brain: neuroprotective effects of cichorium intybus..Int J Diabetes Metabol2009;17:105-9

[68] Lee J.Chicoric acid found in basil (Ocimum basilicum L.) leaves..Food Chem2009;115:650-6

[69] Dalby-Brown L,Landbo AK,Mølgaard P.Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on.in vitro oxidation of human low-density lipoproteins. Agric J Food Chem2005;53:9413-23

[70] Hassan HA.The prophylactic role of some edible wild plants against nitrosamine precursor's experimentally-induced testicular toxicity in male albino rats..J Egypt Soc Toxicol2008;38:1-11

[71] Pool-Zobel B,Rowland I.Experimental evidences on the potential of prebiotic fructans to reduce the risk of colon cancer..Br J Nutr2002;87:273-81

[72] Cavin C,Malnoe A,Touché A,Schilter B.Inhibition of the expression and activity of cyclooxygenase-2 by chicory extract..Biochem Biophys Res Commun2005;327:742-9

[73] Kim JH,Woo WH,An NH.Effects of the ethanol extract of Cichorium intybus on the immunotoxicity by ethanol in mice..Int Immunopharmacol2002;2:733-44

[74] Kolida S,Gibson GR.Prebiotic effect of inulin and oligofructose..Br J Nutr2002;87:S193-7

[75] Van Beek TA,King BM,Voragen AGJ.Bitter sesquiterpene lactones from chicory roots..Agric J Food Chem1990;38:1035-8

[76] Kim M.The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal short-chain fatty acid concentrations and fecal lipid excretion in rats..J Nutr1998;128:1731-6

[77] Roberfroid MB.Inulin-type fructans: functional food ingredients..J Nutr2007;137:S2493-502

[78] Buriti FCA,Filisetti TMCC.Synbiotic potential of fresh cream cheese supplemented with inulin and Lactobacillus paracasei in co-culture with Streptococcus thermophilus..Food Chem2007;104:1605-10

[79] Greenlee H,Yarnell E.Clinical applications of silybum marianum in oncology..Integr Cancer Ther2007;6:158-65

[80] Kroll DJ,Oberlies NH.Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies..Integr Cancer Ther2007;6:110-9

[81] Abenavoli L,Milic N.Milk thistle in liver diseases: past, present, future..Phytother Res2010;24:1423-32

[82] Wang L,Pferschy-Wenzig EM,Liu X,Blazevic T,Rollinger JM,Schuster D,Bauer R,Dirsch VM.Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review..Biochem Pharmacol2014;92:73-89 PMCID:PMC4212005

[83] Al-Anati L,Reinehr R.Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells..Mol Nutr Food Res2009;53:460-6

[84] Fiore C,Ragazzi E,Armanini D.A history of the therapeutic use of liquorice in Europe..J Ethnopharmacol2005;99:317-24

[85] Orazizadeh M,Mansouri E.Effect of glycyrrhizic acid on titanium dioxide nanoparticles-induced hepatotoxicity in rats..Chem Biol Interact2014;220:214-21

[86] Asl MN.Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds..Phytother Res2008;22:709-24

[87] Gwak GY,Lee DH.Glycyrrhizin attenuates HMGB1-induced hepatocyte apoptosis by inhibiting the p38-dependent mitochondrial pathway..World J Gastroenterol2012;18:679-84 PMCID:PMC3281226

[88] Furuta K,Miyake T,Ishine J,Amano Y,Kinoshita Y.Anti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated rats..Oncol Rep2008;19:361-8

[89] El Denshary ES,Mannaa FA,Hassan NS.Dietary honey and ginseng protect against carbon tetrachloride-induced hepatonephrotoxicity in rats..Exp Toxicol Pathol2012;64:753-60

[90] Soldati F.Panax ginseng: standardization and biological activity.In: Cutler SJ, Cutler HG, editors. Biologically active natural products: pharmaceuticals.2000;Boca Raton, FICRC Press209-32

[91] Barnes PM,McFann K.Complementary and alternative medicine use among adults: United States, 2002..Adv Data2004;27:1-19

[92] Oka H,Kuroki T,Marumo T,Monna T,Tango T.Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9)..Cancer1995;76:743-9

[93] Abdel-Wahhab MA,El-Kady AA,Naguib KM.Therapeutic effects of korean red ginseng extract in egyptian patients with chronic liver diseases..Ginseng J Res2011;35:69-79

[94] He SX,Wang YP,Fu H,Zhao G.Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats..World J Gastroenterol2006;12:3924-8 PMCID:PMC4087947

[95] Nishino H,Ii T,Kuchide M,Mou XY,Takayasu J,Masuda M,Konoshima T,Baba M,Okuyama T.Cancer chemoprevention by ginseng in mouse liver and other organs..J Korean Med Sci2001;16:S66-9

[96] Yun TK.Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs..Cancer Epidemiol Biomarkers Prev1995;4:401-8

[97] Hasegawa H,Matsumiya S.Main ginseng saponin metabolites formed by intestinal bacteria..Planta Med1996;62:453-7

[98] Lee BM,Kim HS.Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng)..Cancer Lett1998;132:219-27

[99] Choi HH,Park JH,Lee JW,Otsuki T,Bang YJ.A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells..Int J Oncol2003;23:1087-93

[100] Choi UK,Yim JH,Rhee YK,Kim YC.Hypolipidemic and antioxidant effects of dandelion (taraxacum officinale) root and leaf on cholesterol-fed rabbits..Int J Mol Sci2010;11:67-78 PMCID:PMC2820990

[101] Schütz K,Schieber A.Taraxacum--a review on its phytochemical and pharmacological profile..J Ethnopharmacol2006;107:313-23

[102] Wichtl M.Herbal drugs and phytopharmaceuticals..A handbook for practice on a scientific basis. 3rd ed.2004;Boca Raton, FICRC Press704

[103] Newall CA,Phillipson JD.Herbal medicines: a guide for health-care professionals..1996;LondonPharmaceutical Press296

[104] Jeon HJ,Jung HJ,Lim CJ,Park EH.Anti-inflammatory activity of Taraxacum officinale..J Ethnopharmacol2008;115:82-8

[105] Williams CA,Greenham J.Flavonoids, cinnamic acids and coumarins from the different tissues and medicinal preparations of Taraxacum officinale..Phytochemistry1996;42:121-7

[106] Hu C.Antioxidant, prooxidant, and cytotoxic activities of solvent-fractionated dandelion (Taraxacum officinale) flower extracts in vitro..J Agric Food Chem2003;1:301-10

[107] Al-Malki AL,Abo-Elnaga G.Hepatoprotective effect of dandelion (Taraxacum officinale) against induced chronic liver cirrhosis..Med Plants Res2013;7:1494-505

[108] Park JY,Kim JJ.Hepatoprotective activity of dandelion (Taraxacum officinale) water extract against Dgalactosamine-induced hepatitis in rats..Korean J Soc Food Sci Nut2008;32:177-83

[109] Hudec J,Kobida L,Macho V,Turianica I,Ložek O,Chlebo P.Antioxidant capacity changes and phenolic profile of Echinacea purpea, nettle (Urtica dioica L.), and dandelion (Taraxacum officinale) after application of polyamine and phenolic biosynthesis regulators..Agric J Food Chem2007;55:5689-96

[110] Seo SW,An HJ,Lim BC,Ryu DG,Kim HY,Hong SH.Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats..World J Gastroenterol2005;11:597-9 PMCID:PMC4250819

[111] Rana SV,Vaiphei K,Ola RP.Garlic in health and disease..Nutr Res Rev2011;24:60-71

[112] Herman-Antosiewicz A.Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review..Mutat Res2004;555:121-31

[113] Chu Q,Tsao SW,Wong YC.S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions..BJU Int2007;99:925-32

[114] Gapter LA,Ng KY.S-Allylcysteine reduces breast tumor cell adhesion and invasion..Biochem Biophys Res Commun2008;367:446-51

[115] Tang FY,Chung JG,Hsu CY.S-allylcysteine modulates the expression of E-cadherin and inhibits the malignant progression of human oral cancer..J Nutr Biochem2009;20:1013-20

[116] Welch C,Sidell N.Antiproliferative effect of the garlic compound S-allyl cysteine on human neuroblastoma cells in vitro..Cancer Lett1992;63:211-9

[117] Tang FY,Pai MH.Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model..J Agric Food Chem2010;58:11156-64

[118] Chu YL,Chung JG,Lo YC.Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy..J Agric Food Chem2013;61:9839-48

[119] Bryja V,Schambony A,Schulte G.Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo..Proc Natl Acad Sci U S A2007;104:6690-5 PMCID:PMC1871847

[120] Zhang CL,Zhao XL,Zhu ZP.Protective effects of garlic oil on hepatocarcinoma induced by N-nitrosodiethylamine in rats..Int J Biol Sci2012;8:363-74 PMCID:PMC3291853

[121] Sundaresan S.Prevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by S-allylcysteine..Mol Cell Biochem2008;310:209-14

[122] Darvesh AS,Bishayee A.Curcumin and liver cancer: a review..Curr Pharm Biotechnol2012;13:218-28

[123] Jurenka JS.Anti-inflammatory properties of curcumin, a major constituent of curcima longa: a review of preclinical and clinical research..Altern Med Rev2009;14:141-53

[124] Aggarwal BB,Malani N.Curcumin: the Indian solid gold..Adv Exp Med Biol2007;595:1-75

[125] Reyes-Gordillo K,Shibayama M,Moreno MG.Curcumin protects against acute liver damage in the rat by inhibiting NF-kappa B, proinflammatory cytokines production and oxidative stress..Biochim Biophys Acta2007;1770:989-96

[126] Hsu FT,Liu TT.Curcumin sensitizes hepatocellular carcinoma cells to radiation via suppression of radiation-induced NF-κB activity..Biomed Res Int2015;2015:363671 PMCID:PMC4619792

[127] Soliman MM,Yassin MH.Molecular and histopathological study on the ameliorative effects of curcumin against lead acetate-induced hepatotoxicity and nephrotoxicity in Wistar rats..Biol Trace Elem Res2015;167:91-102

[128] Skommer J,Pelkonen J.Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4..Exp Hematol2007;35:84-95

[129] Dai XZ,Sun LF,Zhou C,Zhang W,Li XC.Potential therapeutic efficacy of curcumin in liver cancer..Asian Pac J Cancer Prev2013;14:3855-9

[130] Aggarwal BB,Bharti AC.Anticancer potential of curcumin: preclinical and clinical studies..Anticancer Res2003;23:363-98

[131] Hamzawy MA,Hassan NS,Abdel-Wahhab MA.Antioxidant and hepatorenoprotective effects of Thyme vulgaris extract in rats during aflatoxicosis..Glob J Pharmacol2012;6:106-17

[132] Hamzawy MA,Abdel-Wahhab MA.Effects of natural compounds in treatment and prevention of hepatotoxicity and hepatocellular carcinoma..Hepatoma Res2015;1:111-8

[133] Hosseinzadeh S,Hosseini A.The application of Thymus vulgaris in traditional and modern medicine: a review..Global J Pharmacol2015;9:260-6

[134] Marculescu A,Hanganu D,Antonie I.Polyphenols analyses from Thymus species..Proc Rom Acad Series B2007;3:117-21

[135] Thompson JD,Michet A,Ehlers B.Qualitative and quantitative variation in monoterpene co-occurrence and composition in the essential oil of Thymus vulgaris chemotypes..J Chem Ecol2003;29:859-80